Skip to main content
BioMaxima S.A. logo

BioMaxima S.A. — Investor Relations & Filings

Ticker · BMX ISIN · PLBIOMX00015 LEI · 2594007GAALFMXP4YB89 WAR Manufacturing
Open in API
Filings indexed 617 across all filing types
Latest filing 2023-03-09 Director's Dealing
Country PL Poland
Listing WAR BMX

About BioMaxima S.A.

https://www.biomaxima.com/

BioMaxima S.A. is a manufacturer specializing in in-vitro diagnostics. The company's primary activities include the development and production of a wide range of products for laboratory diagnostics, with a focus on clinical microbiology. Key product categories include microbiological media, various diagnostic reagents, and specialized laboratory equipment. In addition to its manufacturing operations, BioMaxima also serves as a distributor for products from other global diagnostics firms. The company is actively involved in product innovation, including the development of Minimum Inhibitory Concentration (MIC) tests for antibiotic susceptibility testing.

Recent filings

Filing Released Lang Actions
zwiekszenie_09032023.pdf
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details transactions (Nabycie - Acquisition) involving shares ('akcje') by a person discharging managerial responsibilities ('Przewodniczący Rady Nadzorczej' - Chairman of the Supervisory Board) in the company BioMaxima Spółka Akcyjna. This structure and content explicitly describe insider trading or director's dealing activities as mandated by market abuse regulations (MAR). This directly corresponds to the definition of Director's Dealing (DIRS).
2023-03-09 Polish
Zawiadomienie od osoby zobowiązanej - Content (PL)
Report Publication Announcement Classification · 90% confidence The document text is extremely short (131 characters) and states that the Management Board ('Zarząd') received a notification from Mr. Mariusz Nowak, which is attached to the current report ('które stanowi załącznik do niniejszego raportu'). This structure strongly suggests an announcement about receiving or attaching a document, rather than the content of the document itself. Given the content mentions a notification received by management, it is likely related to insider activity or a significant shareholder change. Since the text explicitly mentions receiving a notification that is attached, and it is not a full report, it fits the criteria for a Report Publication Announcement (RPA) or potentially a Regulatory Filing (RNS) if the attached document is a standard regulatory notice. However, the context of receiving a notification from an individual often relates to Director's Dealing (DIRS) or Major Shareholding (MRQ). Since the text is only an announcement of an attachment, and not the content of the dealing/shareholding itself, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule for short announcement documents. If the attached document were known to be a Director's Dealing report, DIRS would be better, but based solely on this text announcing an attachment, RPA is safer as a publication announcement.
2023-03-09 Polish
Terminy przekazywania raportów okresowych - Content (PL)
Report Publication Announcement Classification · 100% confidence The document is titled "Terminy przekazywania raportów okresowych" (Deadlines for submitting periodic reports) and explicitly lists the scheduled dates for various periodic financial reports for the year 2023 (quarterly reports, semi-annual report, and annual reports for 2022). This is an announcement detailing the schedule for future financial disclosures, not the reports themselves. This fits the definition of an announcement regarding the timing or publication of reports. Therefore, the most appropriate classification is Report Publication Announcement (RPA).
2023-01-30 Polish
Informacja o uzyskaniu dofinansowania w kwocie 1.839.060 zł na zakup linii produkcyjnej - Content (PL)
Regulatory Filings Classification · 99% confidence The document text is a formal announcement from the management ('Zarząd BioMaxima informuje') regarding the receipt of a significant grant (dotacja) of 1,839,060 PLN to fund the purchase of a new production line for SARS-CoV-2 tests and the expansion of production facilities. This announcement details financing activities, capital expenditure plans, and expected future revenue potential resulting from this funding. This content directly relates to updates on company fundraising, financing activities, or capital structure changes, fitting the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV). Given the focus on securing and utilizing grant money for expansion, CAP is the most appropriate classification.
2023-01-16 Polish
zwiekszenie_05122022.pdf
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). Article 19 of the Market Abuse Regulation (MAR) specifically deals with transactions conducted by persons discharging managerial responsibilities (PDMRs). The content details a transaction (Nabycie/Acquisition) of shares by an individual named Mariusz Nowak, who is the Chairman of the Supervisory Board (Przewodniczący Rady Nadzorczej) of BioMaxima Spółka Akcyjna. This clearly indicates an insider transaction report by a director/executive. This matches the definition for Director's Dealing (Code: DIRS).
2022-12-06 Polish
Zawiadomienie od osoby zobowiązanej - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is extremely short (132 characters) and states that the Management Board received a notification from Mr. Mariusz Nowak, which is attached to the current report. This structure strongly suggests an announcement about receiving or attaching a document, rather than the content of the document itself. Given the context of corporate filings, a notification regarding an individual's action (like a director's dealing or a major shareholder change) being attached points towards an insider transaction report or a major shareholding notification. However, since the text only announces the receipt of an attachment without specifying the content (like a trade or share percentage), and it is very brief, it fits the 'Report Publication Announcement' (RPA) criteria if it were announcing the publication of a report, or more generally, a 'Regulatory Filing' (RNS) if it's a mandatory disclosure of an event. Since the text explicitly mentions receiving an attachment to the report, it is a notification about a filing. If the attachment is a Director's Dealing (DIRS) or Major Shareholding (MRQ), this announcement is the cover letter. Given the ambiguity and brevity, and the focus on 'receiving a notification which constitutes an attachment to this report,' it is a general regulatory announcement. However, if we interpret 'powiadomienie' (notification) as the core event being disclosed, and it's not a standard financial report, RNS is the safest fallback. If we strictly follow the 'MENU VS MEAL' rule for short announcements, RPA is for announcing the publication of a report. Since this announces the receipt of a notification/attachment, RNS (General Regulatory Filing) is the most appropriate general category for mandatory, non-standard disclosures.
2022-12-06 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.